Dermapharm Hldg SE/ DE000A2GS5D8 /
11/29/2022 9:05:05 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
42.6840USD | - | 476 Turnover: 20,317.5797 |
-Bid Size: - | -Ask Size: - | 2.07 bill.USD | - | - |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 1.16 EUR | -53.41% |
EPS Diluted: | - EUR | -53.41% |
Revenues per Share: | 21.09 EUR | 10.79% |
Book Value per Share: | 10.01 EUR | 1.43% |
Cash Flow per Share: | 4.08 EUR | -23.94% |
Dividend per Share: | 0.88 EUR | -16.19% |
Total | in mill. | |
Revenues: | 1,135.35 EUR | 10.79% |
Net Income: | 58.11 EUR | -56.18% |
Operating Cash Flow: | 219.42 EUR | - |
Cash and Cash Equivalents: | 158.72 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 29.96 | 36.52 |
P/S Ratio: | 1.65 | 2.01 |
P/BV ratio: | 3.47 | 4.23 |
P/CF Ratio: | 8.53 | 10.39 |
PEG: | -0.56 | -0.68 |
Earnings Yield: | 3.34% | 2.74% |
Dividend Yield: | 2.53% | 2.08% |
Market Capitalization | ||
Market Capitalization: | 2.07 bill. USD | 2.52 bill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | 593,168.7670 USD | 720,655.4052 USD |
Shares Outstanding: | 53.84 mill. |
Profitability
Gross Profit Margin: | - |
EBIT Margin: | 16.11% |
Net Profit Margin: | 5.12% |
Return on Equity: | 10.78% |
Return on Assets: | 2.69% |
Financial Strength
Liquidity I / Cash Ratio: | 40.24% |
Liquidity II / Quick Ratio: | 63.29% |
Liquidity III / Current Ratio: | 159.83% |
Debt / Equity Ratio: | 300.72% |
Dynam. Debt / Equity Ratio: | 738.98% |
Efficiency
Employees: | 3,497 |
Personal Expenses / Employee: | - EUR |
Revenues / Employee: | 324,664.00 EUR |
Net Income / Employee: | 16,617.10 EUR |
Total Assets / Employee: | 617,863.88 EUR |
* Fiscal Year End: | 12/31/2023 |
Accounting Standard: | IFRS |
Currency: | EUR |